Your browser doesn't support javascript.
loading
Metabolomic Pathway Activity with Genomic Single-Nucleotide Polymorphisms Associated with Colorectal Cancer Recurrence and 5-Year Overall Survival.
Fleming, Christina A; Mohan, Helen M; O'Leary, Donal P; Corrigan, Mark; Redmond, H Paul.
Afiliação
  • Fleming CA; Department of Colorectal Surgery, Cork University Hospital, Cork, Ireland. christina.fleming49@gmail.com.
  • Mohan HM; Department of Academic Surgery, Cork University Hospital, Cork, Ireland. christina.fleming49@gmail.com.
  • O'Leary DP; Department of Colorectal Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Corrigan M; Department of Surgical Oncology, Bon Secours Cork Cancer Centre, Cork, Ireland.
  • Redmond HP; Department of Academic Surgery, Cork University Hospital, Cork, Ireland.
J Gastrointest Cancer ; 54(1): 247-258, 2023 Mar.
Article em En | MEDLINE | ID: mdl-35239102
ABSTRACT

PURPOSE:

Metabolomic analysis in colorectal cancer (CRC) is an emerging research area with both prognostic and therapeutic targeting potential. We aimed to identify metabolomic pathway activity prognostic for CRC recurrence and overall survival and cross-reference such metabolomic data with prognostic genomic single-nucleotide polymorphisms (SNPs).

METHODS:

A systematic search of PubMed, Embase and Cochrane Library was performed for studies reporting prognostic metabolomic pathway activity in CRC in keeping with PRISMA guidelines. The QUADOMICS tool was used to assess study quality. MetaboAnalyst software (version4.0) was used to map metabolites that were associated with recurrence and survival in CRC to recognise metabolic pathways and identify genomic SNPs associated with CRC prognosis, referencing the following databases Human Metabolome Database (HMDB), the Small Molecule Pathway Database (SMPDB), PubChem and Kyoto Encyclopaedia of Genes and Genomes (KEGG) Pathway Database.

RESULTS:

Nine studies met the inclusion criteria, reporting on 1117 patients. Increased metabolic activity in the urea cycle (p = 0.002, FDR = 0.198), ammonia recycling (p = 0.004, FDR = 0.359) and glycine and serine metabolism (p = 0.004, FDR = 0.374) was prognostic of CRC recurrence. Increased activity in aspartate metabolism (p < 0.001, FDR = 0.079) and ammonia recycling (p = 0.004, FDR = 0.345) was prognostic of survival. Eight resulting SNPs were prognostic for CRC recurrence (rs2194980, rs1392880, rs2567397, rs715, rs169712, rs2300701, rs313408, rs7018169) and three for survival (rs2194980, rs169712, rs12106698) of which two overlapped with recurrence (rs2194980, rs169712).

CONCLUSIONS:

With a caveat on study heterogeneity, specific metabolites and metabolic pathway activity appear evident in the setting of poor prognostic colorectal cancers and such metabolic signatures are associated with specific genomic SNPs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Polimorfismo de Nucleotídeo Único Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Gastrointest Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Polimorfismo de Nucleotídeo Único Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: J Gastrointest Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irlanda